- Home
- BIVI vs GIGM Comparison
BIVI vs GIGM Comparison
Compare BIVI & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- GIGM
- Stock Information
- Founded
- BIVI 2013
- GIGM 1998
- Country
- BIVI United States
- GIGM Taiwan
- Employees
- BIVI N/A
- GIGM N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- BIVI Health Care
- GIGM Technology
- Exchange
- BIVI Nasdaq
- GIGM Nasdaq
- Market Cap
- BIVI 15.1M
- GIGM 17.9M
- IPO Year
- BIVI N/A
- GIGM 2000
- Fundamental
- Price
- BIVI $1.10
- GIGM $1.44
- Analyst Decision
- BIVI Strong Buy
- GIGM
- Analyst Count
- BIVI 1
- GIGM 0
- Target Price
- BIVI $30.00
- GIGM N/A
- AVG Volume (30 Days)
- BIVI 821.9K
- GIGM 11.8K
- Earning Date
- BIVI 05-12-2025
- GIGM 05-05-2025
- Dividend Yield
- BIVI N/A
- GIGM N/A
- EPS Growth
- BIVI N/A
- GIGM N/A
- EPS
- BIVI N/A
- GIGM N/A
- Revenue
- BIVI N/A
- GIGM $3,103,000.00
- Revenue This Year
- BIVI N/A
- GIGM N/A
- Revenue Next Year
- BIVI N/A
- GIGM N/A
- P/E Ratio
- BIVI N/A
- GIGM N/A
- Revenue Growth
- BIVI N/A
- GIGM N/A
- 52 Week Low
- BIVI $0.62
- GIGM $1.26
- 52 Week High
- BIVI $7.50
- GIGM $1.80
- Technical
- Relative Strength Index (RSI)
- BIVI 54.63
- GIGM 33.95
- Support Level
- BIVI $1.05
- GIGM $1.53
- Resistance Level
- BIVI $1.29
- GIGM $1.50
- Average True Range (ATR)
- BIVI 0.14
- GIGM 0.04
- MACD
- BIVI 0.03
- GIGM -0.01
- Stochastic Oscillator
- BIVI 56.18
- GIGM 5.89
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.